Shopping Cart
- Remove All
Your shopping cart is currently empty
ENFENAMIC ACID
🥰Excellent
Catalog No. T8575Cas No. 23049-93-6
Enfenamic acid is a platelet aggregation inhibitor and with antirheumatic.
ENFENAMIC ACID
🥰Excellent
Purity: 99.46%
Catalog No. T8575Cas No. 23049-93-6
Enfenamic acid is a platelet aggregation inhibitor and with antirheumatic.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $80 | In Stock | |
| 5 mg | $178 | In Stock | |
| 10 mg | $272 | In Stock | |
| 25 mg | $448 | In Stock | |
| 50 mg | $630 | In Stock | |
| 100 mg | $852 | In Stock | |
| 200 mg | $1,130 | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "ENFENAMIC ACID"
Quinine
T0690130-95-0
Quinine is a natural cinchona alkaloid that has been used for centuries in the prevention and therapy of malaria. Quinine is also used for idiopathic muscle cramps. Quinine therapy has been associated with rare instances of hypersensitivity reactions which can be accompanied by hepatitis and mild jaundice.
- $39
Size
QTY
3',4'-Dihydroxyacetophenone
Qingxintong, 4-Acetylpyrocatechol
T37341197-09-7
3',4'-Dihydroxyacetophenone (Qingxintong) is an active constituent of Chinese medicine. It is platelet aggregation Inhibitor and also has anti-arrhythmia activity.
- $29
Size
QTY
4(3H)-Quinazolinone
Quinazolin-4-ol, 4-Quinazolone, 4-Quinazolinone, 4-Quinazolinol, 4-Hydroxyquinazoline
TMO2713491-36-1
4(3H)-Quinazolinone (4-Hydroxyquinazoline) is a chemically synthesized masonry block, a biologically active nitrogen heterocyclic compound. It possesses various biological properties such as antibacterial, antifungal, anticonvulsant, anti-inflammatory, anti-HIV, anticancer and pain relieving activities.
- $48
Size
QTY
Carbasalate calcium
Solupsan, Rheomin, Omegin, Iromin, Carbasalate Calcium, Alcacyl
T36085749-67-7
Carbasalate calcium (Rheomin) is an analgesic, antipyretic, and anti-inflammatory drug, as well as a platelet aggregation inhibitor.
- $34
Size
QTY
Dextran
Dextran 40
T110129004-54-0
Dextran has an inhibitory effect on platelet aggregation and coagulation factors, and is used as an agent for increasing plasma volume.
- $45
Size
QTY
Benzcyclane
Benzcyclan, Bencyclane
T105022179-37-5In house
Benzcyclane (Benzcyclan) is an inhibitor of platelet aggregation and also a vasodilator that can be used in a variety of peripheral circulation disorders.
- $59
Size
QTY
ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate
T98872738381-94-5
ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate is a platelet aggregation inhibitor.
- $195
Size
QTY
48740 RP
RP-55778, RP-48740, RP 55779, RP 55778
T1015993363-11-2In house
48740 RP (RP 55779) is an antagonist of platelet-activating factor.
- $375
Size
QTY
Rocepafant
LAU-8080, LAU8080, LAU 8080, BN-50730, BN50730, BN 50730
T28607132579-32-9In house
Rocepafant (LAU8080) is a platelet-activating factor (PAF) antagonist that attenuates hypoxic-ischemic brain damage in neonatal rats.Rocepafant inhibits tumor necrosis factor-Afa-mediated cytotoxicity in mouse L929 tumor cells.
- $76
Size
QTY
Dersalazine
Dersalazine Free Base
T70084188913-58-8In house
Dersalazine (Dersalazine Free Base), an inhibitor of platelet-activating factor, exerts intestinal anti-inflammatory activity in different rodent types of colitis by down-regulating IL-17 expression, with potential efficacy in patients with ulcerative colitis.
- $210
Size
QTY
DF-1111301
DF1111301, DF 1111301
T27159160665-99-6In house
DF-1111301 is a novel anti-allergic compound with anti-histamine H1 and anti-PAF activity.
- $293
Size
QTY
SDZ-62-434
SDZ62434, SDZ 62 434
T28740115621-95-9In house
SDZ-62-434, a platelet-activating factor inhibitor with antitumor activity, inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells, making it a potential candidate for studying leukemia, human xenograft colorectal cancer, and lung cancer.
- $293
Size
QTY
Select Batch
Purity:99.46%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.Product Introduction
Bioactivity
Chemical Properties
| Description | Enfenamic acid is a platelet aggregation inhibitor and with antirheumatic. |
| In vivo | Dose-matched comparison between zinc-salt of enfenamic acid and the parent compound was carried out in experimentally wounded male albino rats bearing either sutured incision, dead-space or excision wounds. Result showed that enfenamic-acid significantly decreased breaking-strength of incision wounds and this effects was totally reversed by zinc present in enfenamic acid-zinc salt. Both the parent compound and the salt had significant granulation suppressant effect in dead-space wounds. In excision wounds epithelization was enhanced by enfenamic acid only. The wound contraction was not affected by either test compound. |
| Molecular Weight | 241.2851 |
| Formula | C15H15NO2 |
| Cas No. | 23049-93-6 |
| Smiles | OC(=O)c1ccccc1NCCc1ccccc1 |
| Relative Density. | 1.214 g/cm3 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 55 mg/mL (227.95 mM)  | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy ENFENAMIC ACID | purchase ENFENAMIC ACID | ENFENAMIC ACID cost | order ENFENAMIC ACID | ENFENAMIC ACID chemical structure | ENFENAMIC ACID in vivo | ENFENAMIC ACID formula | ENFENAMIC ACID molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.